CURE - Oncology & Cancer News for Patients & Caregivers
CURE - Oncology & Cancer News for Patients & Caregivers
Spotlight
BlogsCancer HorizonsClinical Trial CornerCURE's 20th Anniversary CelebrationPublicationsRecipesVideos
Cancer Type
View MoreBladderBreastCLLKidneyLungMCLOvarianProstateSkin
About CURE
Press ReleasesShare Your StoryWrite for CURE
News
Cancer Horizons
All News
Blogs
Caregiving
Diet and Exercise
Financial
Psychosocial
Recipes
Sexual Health
Side Effect
Sponsored
Survivorship
Videos
All Videos
CURE Connections
CURE Expert Connections
CURE Speaking Out
CURE TV
On Demand: Award Programs
On Demand: Patient Summits
On Demand: Webinars
Conferences
Conference Coverage
Conference Listing
Events
CURE Adventures
Award Programs
Educated Patient Summits
Educated Patient Webinars
Resources
Advocacy Groups
Art Gallery
Clinical Trial Corner
CURE Ambassador Program
Educated Patient Research Updates
Interactive Tools
Journey
Partners
Podcasts
Publications
Share Your Story
Subscribe
CURE Magazine
HEAL Magazine
Sign Up for eNews
  • About
  • Advertise / Support
  • Contact
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information

© 2023 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

Cancer Type
Cancer Type
Bladder | Breast | CLL | Kidney | Lung | MCL | Ovarian | Prostate | Skin
View All >>
Spotlight
Spotlight
Blogs | Cancer Horizons | Clinical Trial Corner | CURE's 20th Anniversary Celebration | Publications | Recipes | Videos
Advertisement

Latest News

View All >>

Gimme Shelter from Lynch Syndrome

February 8th 2023

By Georgia Hurst

On a recent car ride with my son, I asked him if he planned on being tested for Lynch syndrome, the cancer-related syndrome that I have.

PD-L2 Biomarker May Predict Outcomes for Patients with ER-Positive Breast Cancer

February 8th 2023

By Colleen Moretti

The use of PD-L1 to predict outcomes highlights a possible opportunity to better understand which patients with ER-positive breast cancer may benefit from an immune checkpoint inhibitor.

Getting Back to Nature With Cancer

February 8th 2023

By Khevin Barnes

I don’t think of nature as a distraction to my cancer, masking the symptoms or the reality of my disease, but rather as a therapy that offers comfort and serenity with no negative side effects.

Tumor DNA May Predict Outcomes to Presurgical Treatment in Patients with Bladder Cancer

February 8th 2023

By Colleen Moretti

Data suggests an association between tumor DNA circulating in plasma and patient responses to neoadjuvant treatment.

Keytruda Approval Offers ‘Another Form of Insurance’ to Keep Lung Cancer From Returning

February 8th 2023

By Brielle Benyon

An expert discussed the recent approval of Keytruda for non-small cell lung cancer, and what patients with the disease need to know about the newly approved regimen.

Blogs

View All >>

Gimme Shelter from Lynch Syndrome

February 8, 2023 10:00 PM

By Georgia Hurst

Getting Back to Nature With Cancer

February 8, 2023 6:00 PM

By Khevin Barnes

Cancer-Related Muscle Aches May Not Be Fatal, But Are Quite Bothersome

February 7, 2023 6:00 PM

By Jane Biehl Ph.D.

The Sci-Fi World of Cancer Treatment

February 6, 2023 6:00 PM

By Doris Helene White

Publications

View All >>

Avoiding Unavoidable Carcinogens

January 4, 2023 4:00 PM

The Cancerous Legacy of Environmental Toxins

December 30, 2022 8:00 PM

Cholangiocarcinoma: New Hope for a Rare and Aggressive Cancer

December 30, 2022 2:00 PM

Genetic Targets Open the Door to New Treatment Options in Kidney Cancer

December 29, 2022 8:00 PM

Video Series

View All >>
What Patients and Their Families Should Know About Hereditary Breast Cancer
Support is ‘Critical’ for Those Affected By Hereditary Cancers
Making Strides and Breaking Down Barriers in Genetic Testing for Breast Cancer
The Value of Partnerships for Hereditary Cancers
Clinical Trials in Hereditary Cancer Maybe A Key to Better Health Outcomes
The Value of Staying Active During Multiple Myeloma
The Weight of Mental Health During Multiple Myeloma
The Future of Multiple Myeloma Treatment is Bright and Promising
What Does It Mean When Multiple Myeloma Becomes Relapsed/Refractory?
Oncologists Have Feelings Too: Navigating the Patient Physician Relationship
Debunking Myths of Clinical Trials for Cancer
Highlighting Geographic, Economic Disparities in Cancer Care
Jumping Through Insurance Hoops for Treatment
MF Progression to Acute Myeloid Leukemia and Subsequent Treatment
Myelofibrosis: Novel Treatment Strategies and Combination Therapies
Podcasts
View All >>
Teaching Children — and the World — to Use Breathing Techniques for Cancer-Related Pain
Creating an Advocacy Group at the Onset of a Global Pandemic: KRAS Kickers Founder Shares Her Story
Childhood Cancer Survivor Pays It Forward at the Same Hospital She Received Treatment
Welireg Made a von Hippel-Lindau Survivor Feel Like a 'Medical Miracle'
Creating a Charity 8 Days After a Rare Cancer Diagnosis: Dying Defiantly Founder Shares His Story
A Nurse and Parent Explains Navigating Pediatric Oncology During COVID-19
From a 15-Month Prognosis to 17 Years of Survivorship: Heather Von St. James' Mesothelioma Story
Writing a Book Helped a Survivor Process Fears of Cancer Recurrence
From Volunteer to Patient to Advocate: How a Breast Cancer Survivor’s Life Has Changed Over the Years
Reading the Fine Print: How a Footnote on a CT Scan Led to an Unexpected Lung Cancer Diagnosis

Share Your Story

View All >>

We Are All Unique in Our Experiences With Cancer

February 7, 2023 8:00 PM

By Gina Ross

How Cancer Saved Me

February 2, 2023 2:00 PM

By Jayanti Chakraborty

As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis

January 28, 2023 7:00 PM

By Wendy Reichental

Is There a Scale for Cancer Survivorship?

January 26, 2023 2:00 PM

By Stephanie Landon

Advertisement
  Advocacy Group Content

Advocacy Group Content

What Patients and Their Families Should Know About Hereditary Breast Cancer

Support is ‘Critical’ for Those Affected By Hereditary Cancers

Making Strides and Breaking Down Barriers in Genetic Testing for Breast Cancer

The Value of Partnerships for Hereditary Cancers

View More Advocacy Group Content
Advertisement
  • About
  • Advertise / Support
  • Contact
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Write
  • Press Release
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com

© 2023 MJH Life Sciences™ and CureToday. All rights reserved.